Zetia/Zocor Combo User Fee In July 2004; Genentech Sees Avastin On Time
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
The user fee deadline for Merck/Schering-Plough’s Zetia/Zocor combination product for cholesterol reduction is July 24, 2004.